About Bot Image
Bot Image is a medical artificial intelligence company specializing in the interpretation of magnetic resonance imaging (MRI) for healthcare providers. Their flagship product, ProstatID™, is an FDA-cleared software designed to assist physicians in the detection, diagnosis, and screening of prostate cancer using both multi-parametric and bi-parametric MRI. The software utilizes advanced AI algorithms, including random forest with instance weighting and deep learning with nested networks for MR segmentation, to analyze prostate MRI data. ProstatID™ aims to improve the accuracy of prostate cancer detection and reduce false positives by providing a 3D view of the prostate with identified suspicious lesions, along with index scores indicating the likelihood of cancer. This technology is designed to integrate seamlessly into existing PACS, MRI, and viewing stations, offering near real-time diagnostic outputs as a software-as-a-service (SaaS) model.
For physicians, Bot Image’s ProstatID™ offers a valuable tool to enhance the interpretation of prostate MRIs, potentially leading to earlier and more precise intervention for prostate cancer. The software’s ability to provide detailed 3D tumor modeling and lesion identification can assist oncologists in treatment planning and targeting, and urologists in guiding cognitive biopsies. The company emphasizes that ProstatID™ is the first and only software FDA-cleared for detection, diagnosis, and screening of prostate cancer using fast, inexpensive bi-parametric MRI (bpMRI). This technology was initially developed at the National Institutes of Health (NIH) and has demonstrated high accuracy in pilot studies, outperforming seasoned radiologists in some instances. Bot Image also partners with platforms like DeepView Imaging to offer direct-to-consumer AI analysis of prostate MRIs for patients to discuss with their clinicians.
Focus Areas
Business Intelligence
| Technology | Cloud-based, AI operating system (using random forest with instance weight and deep learning with holistically-nested networks for MR segmentation) |
What Physicians Need to Know
For physicians, Bot Image's ProstatIDu2122 offers a powerful tool to significantly improve the accuracy and efficiency of prostate MRI interpretation. It provides a colorized overlay of suspicious lesions with cancer risk scores and PI-RADS scores, aiding in early detection, diagnosis, active surveillance, and treatment planning. The rapid turnaround time of less than five minutes allows for real-time diagnostic assistance, potentially enabling physicians to review results while the patient is still undergoing the MRI. The 3D tumor modeling can greatly assist oncologists in treatment planning and targeting, and urologists in guiding biopsies. Furthermore, the use of non-contrast bpMRI with AI can reduce costs associated with contrast agents and interpretation time, while also decreasing false positives and unwarranted biopsies.
Bot Image is actively working with several MRI systems and agnostic Advanced Visualization and Artificial Intelligence platform providers to integrate their 'dockerized' application into existing systems across the US, Europe, and elsewhere. They also partner with companies like DeepView Imaging to offer direct-to-consumer AI analysis of prostate MRIs, and with platforms like Blackford and ConcertAI's TeraRecon Eureka Clinical AI platform to expand the reach of ProstatIDu2122.
Reviews & Opinions
Videos
News, demos, and interviews about Bot Image.
Videos load interactively. If none appear, search YouTube for Bot Image →
Press & Coverage
Frequently Asked Questions
Comparisons
When choosing between Avenda Health AI Prostate Cancer Planning Software (Unfold AI) and Bot Image’s ProstatID, physicians should consider their primary need: comprehensive treatment planning versus initial detection and risk assessment. Avenda Health’s Unfold AI excels at creating detailed 3D cancer maps from various patient data, including MRI, biopsy, pathology, and PSA. This tool is […]
Related Companies
A2z Radiology AI is a Boston-based medical imaging AI company that develops software for comprehensive CT interpretation, initially focusing on abdomen-pelvis CT scans. The company’s primary goal is to enhance diagnostic accuracy and efficiency in medical imaging for healthcare providers by leveraging artificial intelligence. Their flagship product, a2z-Unified-Triage, is FDA-cleared radiological computer-aided triage and notification […]
OpenAI is an American artificial intelligence (AI) company that conducts research and develops advanced AI models. While widely known for its generative AI models like ChatGPT and DALL-E, OpenAI has significantly expanded its focus into the healthcare sector. The company’s mission is to ensure that artificial general intelligence (AGI) benefits all of humanity, and this […]
Perimeter Medical Imaging AI is a medical technology company dedicated to transforming cancer surgery through the use of ultra-high-resolution, real-time, advanced imaging tools. The company’s mission is to address significant unmet medical needs in cancer surgery, particularly concerning positive margins and the resulting need for re-excisions. Their proprietary technology, including the S-Series Optical Coherence Tomography […]
Veeva Systems is a global leader in cloud-based software solutions specifically designed for the life sciences industry, including pharmaceutical and biotech companies. The company’s offerings are crucial for managing various aspects of drug development, pharmaceutical manufacturing, and commercial operations. Their platforms help clients navigate complex regulatory requirements, improve operational efficiency, and accelerate the delivery of […]
The University at Buffalo (UB) is a prominent public research university and a flagship institution of the State University of New York (SUNY) system. While UB itself is a broad academic institution, the provided URL (halsted.compbio.buffalo.edu) points to a specific area within UB focused on computational biology. This division is actively engaged in healthcare AI […]
SOPHiA GENETICS is a healthcare AI company that has developed a cloud-native, AI-driven SaaS platform called SOPHiA DDM™. This platform is designed to enable hospitals, clinical laboratories, academic medical centers, and biopharmaceutical companies to analyze and interpret complex genomic, radiomic, and multimodal healthcare data. The company’s mission is to democratize data-driven medicine, providing actionable insights […]